Physician profile
Akiko Tanaka
NPI 1174917306
$23,379.05
in general payments reported to CMS, 2019-2025
24 companies · $4,798 in 2025
The $4,798 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $9,162 · 2023: $2,829 · 2024: $6,591 · 2025: $4,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,770 · Travel and Lodging: $5,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,770.05 |
| Travel and Lodging | $5,447.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,799.22 | 2022-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $2,979.39 | 2022-2025 | Mitris Resilia Mitral Valve, Carpentier-Edwards Physio II Annuloplasty Ring |
| W. L. Gore & Associates, INC. | $2,825.72 | 2022-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Penumbra, INC. | $2,289.33 | 2022-2024 | Indigo System |
| Medtronic, INC. | $2,279.85 | 2022-2025 | Endurant Iis, Penditure, Avalus |
| Silk Road Medical, INC. | $1,739.76 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Atricure, INC. | $1,344.23 | 2023-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Cook Medical LLC | $947.51 | 2022-2025 | Cook, Zenith, Icast Covered Stent System, 6mmx22mmx120cm |
| Endologix LLC | $585.96 | 2022-2024 | Endocross Device, Torus Stent Graft System |
| Davol INC. | $372.07 | 2022 | |
| Abbott Laboratories | $330.47 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Navitor |
| Artivion, INC. | $319.96 | 2024-2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Medinc of Texas | $241.05 | 2024 | |
| Limflow INC. | $225.41 | 2023 | Limflow System |
| Abiomed | $152.04 | 2023 | Impella |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $147.48 | 2024 | Coseal |
| Amgen INC. | $141.96 | 2024 | Repatha |
| Inari Medical, INC. | $138.85 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $133.38 | 2022 | |
| Bolton Medical INC | $124.08 | 2023 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $109.69 | 2025 | Artegraft Vascular Graft |
| Sanara Medtech INC. | $99.73 | 2022 | |
| Ethicon US, LLC | $26.38 | 2024 | Harmonic, Stratafix, Surgicel Nu-Knit |
| Imperative Care, INC | $25.53 | 2025 | Symphony Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akiko Tanaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.